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The effects of apoptosis vulnerability markers on
the myocardium in depression after myocardial
infarction
Yiming Wang1,2†, Xingde Liu3†, Dongfeng Zhang1,4, Jianhui Chen1, Shuzheng Liu3 and Michael Berk2,5,6,7*
Abstract
Background: There is an increased incidence of major depressive disorder (MDD) in individuals after myocardial
infarction (MI), but the pathophysiological processes mediating this association are unclear. Our previous study
demonstrated an increase in pro-apoptotic pathways in the myocardium and hippocampus in MDD, which was
reversed by venlafaxine. This study aimed to attempt to confirm the effects of apoptosis vulnerability markers on
the myocardium in a model of depression after myocardial infarction.
Methods: Rats were divided into four groups: sham (N = 8), depression (N = 8, chronic mild unpredictable stress
and separation were used in the depression group), MI (N = 13) and post-MI depression (N = 7). The rats in all four
groups underwent the same open field and sucrose preference behavioral tests. Evan Blue staining was used to
determine the area at risk of myocardial infarction in the left ventricle, and 2,3,5-triphenyl tetrazolium chloride
(1.5% TTC) dye was used to detect the size of the myocardial infarction. The expression of bax and bcl-2 protein in
the myocardium was investigated by immunohistochemistry, and the mRNA expression of bax, bcl-2 and caspase-3
in the myocardium was investigated by real time RT-PCR. Apoptosis was estimated in the myocardium by
measuring the Bax:Bcl-2 ratio.
Results: In the depression and post-MI depression rats, there were significantly decreased movements and total
sucrose consumption, modeling behavioral deficits and an anhedonic-like state. In terms of myocardial infarction
size, no difference was seen between the MI and post-MI depression groups. There was an up-regulated Bax:Bcl-2
ratio in the depression, MI and post-MI depression groups. Furthermore, in the latter group, there was a greater
up-regulated Bax:Bcl-2 ratio. However, caspase-3 did not differ among the four groups.
Conclusions: These results of this animal model suggest that active pro-apoptotic pathways may be involved in
the nexus between myocardial infarction and depression. This mechanism may be germane to understanding this
relationship in humans.
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Background
Depression is a major contribution to the global disease
burden, and is widely accepted as an independent risk
factor in patients with coronary artery disease (CAD).
Comorbidity is associated with poorer outcomes [1-5].
Myocardial infarction (MI) is the most serious clinical
form of CAD [6]. There is an increased incidence of
major depressive disorder (MDD) (15 to 30%) after
myocardial infarction (MI) [7]. Equally, depression is
linked to a 2.0- to 2.5-fold increased risk in new cardio-
vascular events and increased cardiac mortality [8-10].
Patients frequently develop depressive symptoms after
an acute MI, and depression is linked to an increased
long-term risk of morbidity and mortality [11]; however,
the pathophysiological mechanisms underpinning the
relationship between MI and depression remain poorly
understood.
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Apoptosis or programmed cell death is a process of
ordered, active, non- inflammatory cell death. Bcl-2 is
one member of a family of genes which can be divided
into two categories according to their effects on apopto-
sis, one group promoting apoptosis, including Bax, Bak,
Bad and Bcl-xS, a second group inhibiting cell death
pathways, including Bcl-2 and Bcl-xl [12,13]. Of these
proteins, Bcl-2, Bax and Bcl-x are the best characterized
genes in the Bcl-2 family [14]. In the presence of stress,
Bcl-2 family proteins congregate at the outer mitochon-
drial membrane and play a role in the regulation of
apoptosis. Pro-apoptotic Bax and Bak undergo confor-
mational changes and Bax translocates from cytosol to
mitochondria via homo-oligomerization with cell stress
signals [15].
The Bax/Bcl-2 ratio is a measure of a cell’s vulnerabil-
ity to apoptosis, a higher Bax/Bcl-2 ratio is associated
with a greater vulnerability to apoptotic activation, and
up-regulation of the Bax/Bcl-2 ratio suggests greater
apoptotic activity [16,17]. Antidepressants, such as ser-
traline, can modulate depression-induced behavior and
biochemical markers after myocardial infarction [18].
Caspases are a family of inactive proenzymes. Gener-
ally, there are two pathways in caspase family proteases
which can be activated: one is the death receptor-
mediated pathway that is death signal-induced; another is
the mitochondrion-mediated stress-induced pathway that
truncates a pro-apoptotic Bcl-2 family member [19].
Caspase-3 is a protein that regulates apoptosis by indu-
cing the cleavage of the key cellular proteins and alters cell
integrity. The role of caspase 3 in apoptosis is to activate
the stages of cellular death in a non-traumatic manner.
Activation of caspase-3 is another pathway to apoptosis.
It has been recently demonstrated that the release of
pro-inflammatory cytokines in rats can induce limbic
system apoptosis after an acute myocardial infarction
[20-22]. Wann [23] has shown behavioral changes and
an increased Bax/Bcl-2 protein ratio in limbic areas in
rats with post-MI depression, suggesting a role of apop-
totic events, which is similar to human findings.
Our previous study [24] demonstrated that in rats with
chronic mild stress (CMS), there were significant beha-
vioral deficits, an increase in Bax levels and a decrease in
Bcl-xl levels in the myocardium and hippocampus, sug-
gesting an increase in pro-apoptotic pathways. This was
reversed by venlafaxine, which is an antidepressant of the
serotonin-norepinephrine reuptake inhibitor (SNRI)
class; however, in models of post-MI with depression, the
role of apoptosis vulnerability markers in the myocar-
dium is unclear, in particular associations with apoptotic
pathways. We consequently hypothesized that active pro-
apoptotic pathways in the myocardium may be involved
in the nexus between cardiovascular disorders and
depression.
To investigate this issue, we developed a valid model of
myocardial infarction, alone and in conjunction with an
anhedonic-like state in rats. This study aimed to attempt
to evaluate vulnerability markers of myocardial apoptosis,
specifically the Bax:Bcl-2 ratio and caspase-3 levels in the
myocardium post-MI depression, to clarify the molecular
mechanisms and, as well, confirm whether the co-occur-
rence of myocardial infarction with MDD is associated
with greater activation of apoptosis pathways.
Methods
Subjects
Male Sprague-Dawley rats (N = 36, weighing 250 g ± 20 g)
were used for the experimental procedures. Rats were
allowed to adapt to the surroundings for one week prior
to the commencement of the experiment. Each rat was
housed singly at room temperature (22 to 25°C), humidity
(40 to 50%), the light period was 12 h from 8 a.m., and
food and water were freely available. Rats were divided
into four groups: (i) sham group (N = 8), (ii) depression
group (N = 8), (iii) MI group (N = 13), (iv) post-MI
depression group (N = 7). The rats in all four groups per-
formed the same open field and sucrose preference beha-
vioral tests. In the depression and post-MI depression rats,
there were significantly decreased movements and reduced
total sucrose consumption, modeling behavioral deficits
and a depressive-like anhedonic state [25]. The model of
post-MI depression, in which decreased movement and an
anhedonic- state occurred, was observed in 7 out of 20
myocardial infarction rats in our experiment. Animals
were managed in accordance with the American Psycholo-
gical Association (APA) ethical standards in the treatment
of rats and National Institute of Health and Guide for the
Care and Use of Laboratory Animals (NIH Publications
No. 80-23) revised in 1996, and the study was approved by
the ethics Committee on the Guidelines for Animal
Experiment at Guiyang Medical University. Efforts were
made to minimize the number of animals used and their
suffering.
Myocardial infarction model (MI group)
In this study, we used the myocardial infarction model of
ischemia described by Wu et al., which is a validated ani-
mal model of myocardial infarction [26]. Surgeries were
performed in the morning. Twenty- two rats were anesthe-
tized by 10% chloral hydrate (0.3 ml/100 g), intubated, and
maintained on a ventilator (R: 60 times/minute). A thoracic
incision of about 2.0 cm was made, and the base of the
heart was exposed by retractors in the central region of the
rib cage. The myocardial infarction model was induced by
ligating the left anterior descending coronary artery 2 mm
from the tip of the left auricle by polypropylene suture for
40 minutes. Rats were monitored by ECG (electrocardio-
gram) before and after coronary artery ligation. Ischemia
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was confirmed by ST-T segment elevation in ECG record-
ings performed on the rats (Figure 1) [27], and after the
myocardial surface became blanched, the animal was
returned to its home cage after the ligation was removed
and the thorax sutured for 14 days. In the sham group,
eight rats were operated on using the same protocol,
except the coronary artery was not ligated. After the sur-
gery, all rats were administered an analgesic (2 mg/kg
butorphanol tartrate, s.c. every 8 h during the 24 h after
surgery) and an antibiotic (10,000 IU penicillin G, i.m.).
The rats did not show any signs of cardiac failure nor
arrhythmias during the myocardial infarction procedure.
The percentage of rats surviving the MI induction proce-
dure was 90%.
Chronic mild stress model (depression)
In this study, the chronic mild stress model was used as a
validated animal model of depression [28]. Chronic mild
unpredictable stress and separation were used in the
depression group for 21 days. Eight rats were given the fol-
lowing stressors [25,29], consisting each week of repeated
periods of confinement to a small (38 × 20 ×16 cm) cage,
restraint (1 h), water deprivation (24 h), food deprivation
(24 h), isolation (24 h), flashing light (3 h), forced cold
water swimming (10 minutes) and were group-housed in a
soiled cage overnight. Individual stressors and length of
time used each day are listed in Table 1. Stressors were
used daily in a random and unpredictable order for
21 days.
Open field test and sucrose consumption test
The behavior and anhedonic-like state of all rats were
detected by the open field test [30] and sucrose
consumption test [31]. The behavioral response to a
new environment and activating behavior of rats was
detected by the open field test [32], which has been
used as an indicator of emotional state. This includes
assessment of horizontal movements (the total number
of crossing squares) and vertical movements (grooming
and rearing) during a five-minute period. The former
can be used as a proxy of emotional activity; the latter is
regarded as a measure of exploratory activity to novel
environments [33]. A special white square (80 × 80 × 40
cm), which has 25 sectors with black stripes on the
ground, was used. Animals were separately put in the
same central sector, and their activity was recorded dur-
ing a five-minute period by an installed video camera.
Observers analyzed the results of videotapes. Rats in
both the depression and post-MI depression groups
showed significantly lower scores of both horizontal and
vertical movement compared with the sham and MI
groups (Figure 2A), suggesting similarly decreased beha-
vioral indices in the post-MI depression and depression
groups.
Sucrose consumption is a rat model of an anhedonia-
like state [34]. Every cage was offered a bottle of water and
a bottle of 1% sucrose water. Total sucrose consumption
was measured after 60 minutes. The test was begun 23 h
after water and food deprivation, and the experiment was
begun, and on day 15 after surgery [23] and the day after
the end of the chronic mild unpredictable stress procedure
[28]. Before the experiment, there were similar levels of
sucrose water consumption between the four groups; how-
ever, after the experiment, the total consumptions of
sucrose was significantly lower in the depression and post-
MI depression groups compared to the sham and MI
A                                                                                 B 
 
 
 
 
 
 
Figure 1 The electrocardiogram of the rats. A: Electrocardiogram in the normal rat. B: ST-segment elevation in leads I in myocardial ischemia
rat.
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groups (Figure 2B), suggesting the post-MI depression
group was similar to the depression group in terms of
developing an anhedonic-like state.
Myocardial infarct size
The rats were sacrificed by decapitation 24 h after com-
pletion of the behavioral tests, prior to which horizontal
movements, vertical movements and sucrose consump-
tion tests were recorded according to the experimental
protocol. The heart was removed, and the aorta was can-
nulated and washed with saline, the left anterior descend-
ing coronary artery was ligated again at the same site, and
the aorta was infused with 2 ml of 0.5% Evan’s blue to
determine the extent of the non-colored ischemic risk
area, then the myocardium was bisected into two parts
from the apex to the base along the left anterior descend-
ing coronary artery, which was frozen at -80°C for five
minutes, and then sliced into 2 mm transverse sections
and stained using 2,3,5-triphenyl tetrazolium chloride
(1.5%TTC) and myocardial infarction size (×2) was thus
confirmed [21]).
Tissue preparation
The rest of the myocardium was washed using DEPC
(diethylpyrocarbonate) H2O. The anterior myocardial
regional tissue sample (50 mg), which was non-colored tis-
sue using Evan’s blue was separated from the edge of the
myocardial infarct risk area of the left ventricle. Tissue
was frozen using liquid nitrogen and stored at -80°C for
future real time RT-PCR use; the remainder was put into
4% paraformaldehyde for 12 h, paraffin embedded, and
sectioned (thickness of 4 μm) for immunohistochemical
staining.
The expression of Bax, Bcl-2 and caspase-3 mRNA was
detected by real time RT-PCR
Total RNA was extracted from the samples by the TRI-
ZOL reagent (Shanghai ShengGong Biological Engineering
Table 1 Schedule of chronic mild stress
Monday Tuesday Wednesday Thursday Friday Saturday Sunday
Stressor
used
Restraint Water
deprivation
Food
deprivation
Isolation Flashing
light
Forced cold water
swimming
Group-housed in soiled
cage
Duration 1 h 24 h 24 h 24 h 3 h 10 minutes overnight
Figure 2 The behavioral changes in open-field and sucrose consumption test. Rats in both the depression and post-MI (myocardial
infarction) depression groups showed significantly lower scores of both horizontal and vertical movement compared with the sham and MI
groups (a P < 0.01) (A). The total consumptions of sucrose was significantly lower in the depression and post-MI depression groups compared to
the sham and MI groups after the experiment (a P < 0.01, b P < 0.05) (B).
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Services Co., LTD, Shanghai, China). Primers were synthe-
sized (Shanghai ShengGong Biological Engineering
Services Co., LTD, Shanghai, China). cDNA was synthe-
sized (Invitrogen Corp., San Diego, California USA) by
combining the components (5× VILO™ Reaction Mix 4
μl, 10× Superscript Enzyme Mix 2 μl, RNA (up to 2.5 μg)
Xμl and DEPC-treated water to 20 μl). Tube contents
were gently mixed and incubated at 25°C for 10 minutes.
Tubes were incubated at 42°C for 60 minutes. The reac-
tion was terminated at 85°C at 5 minutes. cDNA was
amplified with Power SYBR Green PCR Master Mix
(Roche Molecular Biochemicals, Basel, Switzerland) for
each gene, by the Applied Biosystems StepOne™ and Ste-
pone Plus™ real-time PCR System (Foster City, California,
USA): pre-denaturation 95°C for 10 minutes, denaturation
95°C for 15 s, annealing 60°C for 1 minute, extending 72°C
for 1 minute, denaturation and annealing for a total of 40
cycles, extending again 72°C for 10 minutes. PCR products
were analyzed by quantitative high-resolution DNA melt-
ing analysis. b-actin was used as an internal standard.
Table 2 shows Primer series of Bax, Bcl-2 and b-actin, cas-
pase-3 gene.
Quantitative measure of Bcl-2 and Bax protein by
immunohistochemical staining
For Bax and Bcl-2 protein determination [35], immunohis-
tochemical staining kits for Bax, Bcl-2 were provided by
Wuhan Boster Bioengineering Co., Ltd. (Wuhan, China).
The sections (thickness of 4 μm) were de-waxed and rehy-
drated with freshly distilled water. At room temperature,
samples underwent inactivation of endogenous peroxidase
for 10 minutes and were washed with distilled water for
2 minutes (three times), then immersed in 0.1 mol/L
citrate buffer solution (pH = 6.0) and heated in a micro-
wave oven until boiling (twice, with a 5-minute interval).
After refrigerated flushing three times with phosphate buf-
fered saline (PBS) for 2 minutes, antigen-retrieval buffers
were added for 10 minutes and tissues were then flushed
three times with PBS for 2 minutes. At room temperature,
samples were non-specifically blocked with normal goat
serum for 20 minutes. After removal of the goat serum,
rabbit anti-Bax, Bcl-2 antibody was added (incubated for
60 minutes at 37°C). Biotinylated goat anti-rabbit antibody
immunoglobulin G was applied for 20 minutes and
flushed with PBS for 2 minutes (three times), then the tis-
sues were placed in a streptavidin-biotin-enzyme complex
reagent, incubated for 20 minutes at 37°C, after flushing
with PBS for 5 minutes (four times), samples were stained
with diaminobenzidine for 25 minutes and washed for 3
minutes. Then samples were stained with hematoxylin,
and were dehydrated and mounted for microscopic exami-
nation. Images of the sections were obtained (400 X) using
the Image-Pro Plus 4.5 software (Media Cybernetics, Sil-
ver. Spring, USA) with brown cytoplasmic staining under
light microscopy indicating a positive reaction of Bax, Bcl-
2. The myocardial infarction border zone was chosen
using a 10 high power fields (400×), in which the mean
number of bax and bcl-2 positive cells were obtained. The
Bax:Bcl-2 ratio was also confirmed.
Statistical analysis
The analyses were conducted using IBM SPSS 19.0 analy-
sis software (SPSS Inc, Chicago, Illinois, USA). One-way
ANOVA test was performed to examine the data among
groups (mean ± SEM) with the Bonferroni post-hoc tests
for multiple comparisons. There was a significant differ-
ence (P < 0.05) and all the statistical tests were two-tailed.
Results
Infarct size
The myocardial infarct risk area of the left ventricular
area was 65 ± 2% (mean ± SEM) indicated by Evan Blue
staining. The myocardial infarct size in the myocardial
infarct risk area was similar in both groups: (MI group
43.2 ± 1.9%; post-MI depression group 45.6 ± 2.6%). No
difference was seen between the MI and post-MI
depression groups.
The expression of Bax and Bcl-2 mRNA and Bax/Bcl-2
ratio
The ratio of Bax:Bcl-2 (mean ± SEM) in the depression,
MI and post-MI depression groups was statistically sig-
nificantly larger than in the sham group (P < 0.05). The
ratio of Bax-Bcl-2 was significantly larger in MI group
than the depression group (P < 0.05), and this ratio was
significantly greater in the post-MI depression group
compared with the MI group (P < 0.05) (Table 3).
The expression of Bax and Bcl-2 protein and Bax/Bcl-2
ratio
There was a significantly higher ratio of Bax:Bcl-2 (mean ±
SEM) in the myocardium in the depression, MI and post-
MI depression groups than in the sham group (P < 0.01).
Furthermore, in the post-MI depression group there was a
Table 2 Primer series of Bax, Bcl-2, b-actin and caspase-3
Genes upstream (5’-3’) downstream (5’-3’) Bp
Bax GCGATGAACTGGACAACAACAT TAGCAAAGTAGAAAAGGGCAACC 153
Bcl-2 ATGTGTGTGGAGAGCGTCAACC CCAGGAGAAATCAAACAGAGGC 174
b-actin ATGGTGGGTATGGGTCAGAA ACCCTCATAGATGGGCACAG 375
caspase-3 TGGTTCATCCAGTCGCTTTGT CAAATTCTGTTGCCACCTTTCG 103
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significantly higher ratio of Bax:Bcl-2 than in the depres-
sion and MI groups (P < 0.01), and in the MI group there
was a significantly higher ratio of Bax:Bcl-2 than in the
depression group (P < 0.01) (Table 4).
Caspase-3 levels
No difference was seen in caspase-3 levels among the
sham, depression, MI and post-MI depression groups
(Table 3).
Discussion
There is an established link between depression and myo-
cardial infarction in morbidity; however, the mechanisms
underpinning this association are not comprehensively
elucidated [36]. In this study, we demonstrated the beha-
vioral phenotype of depression after myocardial infarction,
characterized by lower scores of horizontal movements,
vertical movements and reduced consumption of sucrose
solution, in the depression and post-MI depression rats.
These are models of lowered emotional activity and
exploratory behavior, where the post-MI depression group
demonstrated altered reward preference.
Apoptosis is an ordered, active, non-inflammatory pro-
cess of cell death caused by a pathological or physiologi-
cal stimulation of a genetically mediated regulatory
system. Previous studies have demonstrated that in ische-
mia and reperfusion damage, apoptosis in the myocar-
dium plays a role in the pathology of heart diseases,
including myocardial infarction and dilated cardiomyopa-
thy [21,37]. Cardiomyocyte apoptosis is a key form of cell
death, and apoptotic cell death plays an important role in
the development of heart failure [38].
There are two major apoptotic pathways in mammalian
cells, ‘‘intrinsic’’ and ‘‘extrinsic’’. Both kinds of apoptotic
pathways were observed simultaneously in the experiment
secondary to activation and non-activation of caspase-3,
which may cause cleavage of substrates and cell death.
The mitochondrial-mediated pathway of apoptosis is regu-
lated by the Bcl-2 family of antiapoptotic (Bcl-2, Bcl-xl,
Mcl-1) and proapoptotic proteins (Bax, Bad and Bak), and
Bcl-2 inhibits apoptosis by interacting and forming inacti-
vating heterodimers with Bax/Bak. It has been suggested
that the Bax/Bcl-2 ratio may be more important than
either promoter alone in determining apoptosis. The Bax/
Bcl-2 ratio is a measure of a cell’s vulnerability to apopto-
sis; therefore, in our study, the use of a more sensitive,
Bax/Bcl-2 ratio predominantly reflected apoptosis. In myo-
cytes, the ‘intrinsic’’ pathway is primarily activated when
cells are stimulated by hypoxia, ischemia-reperfusion and
oxidative stress [26]. Oxidative stress has been hypothe-
sized in part to mediate the link between somatic and psy-
chiatric disorders [39]. Cardiac dysfunction and heart
failure are documented after acute emotional stress [40].
The pathway of apoptosis is influenced by the Bax/Bcl-2
ratio and activated caspase-3. A high Bax/Bcl-2 ratio is
associated with greater vulnerability to apoptotic activa-
tion, while a high caspase-3 level is often associated with
apoptotic activity.
We observed that there was an increased myocardial
Bax:Bcl-2 ratio in the depression, MI and post-MI depres-
sion groups, this was particularly so in the latter group,
where there was a greater Bax:Bcl-2 ratio which is impor-
tant in determining a cell’s vulnerability to apoptosis.
Up-regulation of the Bax/Bcl-2 ratio can induce greater
Table 3 The expression of caspase 3, Bax and Bcl-2 mRNA and Bax/Bcl-2 ratio (mean ± SEM, copies/g RNA)
Groups Casp-3 mRNA Bax mRNA BcL-2 mRNA Bax/bcl-2
Sham (8) 0.66 (0.34) 2.85 (0.58) 0.88 (0.19) 3.29 (0.67)
Depression (8) 0.67 (0.08) 10.73 (1.20)a 1.97 (0.26) a 5.55 (1.28) b
MI (13) 0.92 (0.55) 23.23 (1.97)a, c 3.12 (0.10) a, c 7.47 (0.86) a, d
Post-MI Depression (7) 0.95 (0.42) 46.79 (2.75)a, c, e 5.08 (0.55) a, c, e 9.26 (0.67) a, c, f
F 0.481 333.978 93.541 24.171
P 0.704 0.000 0.000 0.000
The ratio of Bax:Bcl-2 (mean ± SEM) in the depression, MI (myocardial infarction) and post-MI depression groups was significantly larger than in the sham group
(a P < 0.01, b P < 0.05), the MI and post-MI depression group was significantly larger than the depression group (c P < 0.01, d P < 0.05), and the post-MI
depression group was a significantly greater than the MI group (e P < 0.01, f P < 0.05).
Table 4 The expression of Bax and Bcl-2 protein and Bax/Bcl-2 ratio (mean ± SEM, IOD)
Groups (n) Bax Bcl-2 Bax/Bcl-2
Sham (8) 3.32 (0.92) 2.74 (1.03) 1.14 (0.22)
Depression (8) 9.47 (2.5)a 6.18 (2.21)a 1.55 (0.30)a
MI (13) 27.63 (5.61)a, b 9.42 (3.75)a 2.83 (0.51)a, b
Post-MI depression (7) 53.88 (16.18)a, b, c 14.82 (3.71)a, c 3.77 (0.64)a, b, c
There was a significantly higher ratio of Bax:Bcl-2 (mean ± SEM) in the myocardium in the depression, MI (myocardial infarction) and post-MI depression groups
than in the sham group (a P < 0.01). Furthermore, in the post-MI depression and MI groups there was a significantly higher ratio of Bax:Bcl-2 than in the
depression group(b P < 0.01), and in the post-MI group there was a significantly higher ratio of Bax:Bcl-2 than in the MI group (c P < 0.01).
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apoptotic activity [16,17], suggesting that there was greater
vulnerability to apoptosis of myocardial cells with acute
myocardial infarction with comorbid major depression.
These data suggest that post-MI depression can activate
pro-apopotic pathways; however, the regulatory mechan-
isms underlying apoptosis in the myocardium remain
unclear.
This study also demonstrated that the up-regulated
Bax/Bcl-2 ratio may modulate apoptosis associated with
progression of the disease [41]. The Bax/Bcl-2 ratio may
serve as an independent predictive marker of the thera-
peutic response [42], and merits further examination, as
the myocardial infarction with depression induced
increase of the Bax/Bcl-2 ratio might enhance apoptosis
of cardiomyocyte [43,44]. These data suggest that
depression after myocardial infarction may increase the
Bax/Bcl-2 ratio and induce further cardiomyocyte apop-
tosis, which may play an important role in the higher
morbidity after myocardial infarction in conjunction
with depression.
Contrary to hypotheses, we found no difference in cas-
pase-3 in the myocardium of the post-MI depression
group versus the MI, depression and sham groups. This
may indicate that caspase-3 is not an active pathway to
apoptosis in the myocardium in the model of myocardial
infarction with depression. In interpreting this, several
factors should be considered. First, caspase-3 may not be
activated during the post-MI depression. It is possible
that caspase-3 activity was low because the apoptotic
process in the myocardium was only finished two weeks
post-MI. Second, it is possible that caspase-3 activity may
induce apoptosis via another independent pathway.
Third, the up-regulated Bax/Bcl-2 ratio may decrease the
cell’s viability in involving other effector caspases without
the activity of caspase-3 [16]. Other caspases may be
involved. Lancel et al. [45] showed that endotoxin
induced increases in ventricular cardiomyocyte caspase-
3, -8 and -9-like activities. This was associated with sar-
comeric structure damage and cleavage of components of
the cardiac myofilament. Frantz et al. [46] noted that rats
with deletion of the caspase-1 gene showed increased
peri-infarct survival and a lower rate of ventricular dilata-
tion and a decreased rate of apoptosis after a model of
myocardial infarction.
However, we did not find a relationship between other
caspases and the model of MI with depression. Apoptotic
pathways may interact with other pathways of shared risk
including ischemia and reperfusion damage, inflamma-
tory and oxidative pathways [38,47,48] and other non-
specific mechanisms, suggesting the need for further
exploration of these interactions.
In this study, we found a depressive-analog anhedonia-
like state in rats after myocardial infarction. These changes
have parallels with the core symptoms of depression.
There may be a mechanistic association with the up-regu-
lation of the Bax/Bcl-2 ratio in the myocardium after
myocardial infarction with depression. Our study demon-
strated that in rats with post-MI depression, there is an
increase in pro-apoptotic pathways in myocardium after
myocardial infarction. Cardiomyocyte apoptosis is a key
form of cell death, and apoptotic cell death plays an
important role in the development of heart failure [38],
resulting in a decreased heart function and reduced car-
diac output.
There are certain limitations that need to be kept in
mind when interpreting these data. First, our previous
study demonstrated that in rats with chronic mild stress,
there is an increase in pro-apoptotic pathways in the myo-
cardium and hippocampus after depression, which was
reversed by venlafaxine. To extend this line of study, our
purpose was to attempt to evaluate myocardial apoptosis
after myocardial infarction with depression, to clarify the
molecular mechanisms, as well as confirm whether the
higher incidence of myocardial infarction with depression
is associated with apoptosis pathways, so the use of an
inhibitor of apoptosis after myocardial infarction may
further clarify the role of apoptosis. Similarly, the use of a
chronic unpredictable stress-depressed (depression) group
on which surgery is performed as another “control” group
could have assisted interpretation of these results. Second,
in our experiment, only 7 out of 20 myocardial infarction
rats developed an anhedonic-like state compared to sham
and depression groups; this pattern differs from reports by
other groups and may be related to methodological var-
iance. Third, it would also have been helpful for the
sucrose test to have been done weekly in addition to base-
line and endpoint readings. Further experimentation will
clarify this point. In addition, although our results showed
no effect of caspase-3 level in the myocardium after myo-
cardial infarction and depression, it may induce apoptosis
via an independent caspase-3 pathway, or other caspases
expressed in the heart, suggesting again the need for
further study.
Conclusions
The results of this animal model suggest that active pro-
apoptotic pathways may be involved in the nexus between
cardiovascular disorders and depression. The operative
mechanism might be the effects of apoptosis vulnerability
markers on the myocardium in the model of depression
after myocardial infarction. Apoptotic pathways may inter-
act with other pathways of shared risk including ischemia
and reperfusion damage, inflammatory and oxidative path-
ways, and other non-specific mechanisms. These data
nevertheless suggest that active pro-apoptotic pathways
may be involved in the morbidity after myocardial infarc-
tion in those with MDD. This mechanism may be ger-
mane to understanding this relationship in humans.
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A clear understanding of these pathways could shed light
on the potential protective effects from further heart
damage after myocardial infarction with depression, as
well as their effects on common pathways to medical
comorbidity.
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